The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Glioblastoma: clinical presentation, diagnosis, and management
Open accessAbstract
What you need to know Early symptoms of brain tumours in adults are non-specific, and patients may present multiple times to primary care services before they are referred for investigation. Look for symptoms of raised intracranial pressure (such as headaches exacerbated by lying down, triggered by the Valsalva manoeuvre, or associated with vomiting or visual disturbance), combinations of symptoms (such as headache plus cognitive impairment, headache plus weakness, headache plus personality change), and symptoms that progress over time. New onset focal or generalised seizures in adulthood also warrant investigation for a brain tumour. In patients with symptoms or signs suggestive of a brain tumour, arrange urgent magnetic resonance imaging of the head with and without contrast through a rapid access “suspected cancer” pathway, when available. In patients with suspicion of raised intracranial pressure, arrange a same day clinical assessment and contrast enhanced computed tomography of the head. Glioblastoma is the most common primary brain cancer. Standard treatment includes maximal safe resection followed by concomitant radiotherapy and temozolomide chemotherapy and then adjuvant temozolomide. Disease progression is expected in all cases and consideration of further treatment should take into account the patient’s performance status, tumour size, tumour location, and time since first treatment. Key supportive medications may include corticosteroids for vasogenic oedema and antiepileptic medication if seizures occur. Because of the incurable and rapidly progressive nature of glioblastoma, close collaboration between multidisciplinary teams in tertiary care hospitals and primary care services is recommended. Early involvement of general practitioners and specialist community palliative care teams can assist patients and caregivers with advance care planning as well as management of symptoms, physical and cognitive impairment, communication difficulties, and the innate uncertainties about disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
The epidemiology of glioma in adults: a "state of the science" review
Ostrom, Q. T., Bauchet, L., Davis, F. G., Deltour, I., Fisher, J. L., Langer, C. E., Pekmezci, M., Schwartzbaum, J. A., Turner, M. C., Walsh, K. M., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou087 · Cited by 2,220
Ostrom, Q. T., Gittleman, H., Truitt, G., Boscia, A., Kruchko, C., & Barnholtz-Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy131 · Cited by 2,138
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Weller, M., van den Bent, M., Preusser, M., Le Rhun, E., Tonn, J. C., Minniti, G., Bendszus, M., Balana, C., Chinot, O., Dirven, L., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00447-z · Cited by 2,048
Management of glioblastoma: State of the art and future directions
Tan, A. C., Ashley, D. M., López, G. Y., Malinzak, M., Friedman, H. S., & Khasraw, M. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21613 · Cited by 1,972
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Thakkar, J. P., Dolecek, T. A., Horbinski, C., Ostrom, Q. T., Lightner, D. D., Barnholtz-Sloan, J. S., & Villano, J. L. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0275 · Cited by 1,390
Primary brain tumours in adults
Lapointe, S., Perry, A., & Butowski, N. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30990-5 · Cited by 1,366
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
Perry, J. R., Laperriere, N., O’Callaghan, C. J., Brandes, A. A., Menten, J., Phillips, C., Fay, M., Nishikawa, R., Cairncross, J. G., Roa, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611977 · Cited by 1,172
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Brown, T. J., Brennan, M. C., Li, M., Church, E. W., Brandmeir, N. J., Rakszawski, K. L., Patel, A. S., Rizk, E. B., Suki, D., Sawaya, R., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1373 · Cited by 1,081
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management
van Breemen, M. S., Wilms, E. B., & Vecht, C. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70103-5 · Cited by 913
Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis
Morris, Z., Whiteley, W. N., Longstreth, W. T., Weber, F., Lee, Y.-C., Tsushima, Y., Alphs, H., Ladd, S. C., Warlow, C., Wardlaw, J. M., et al. (2009) · BMJ · doi:10.1136/bmj.b3016 · Cited by 792
Glioblastoma: pathology, molecular mechanisms and markers
Aldape, K., Zadeh, G., Mansouri, S., Reifenberger, G., & von Deimling, A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1432-1 · Cited by 735
Advances in the molecular genetics of gliomas — implications for classification and therapy
Reifenberger, G., Wirsching, H.-G., Knobbe-Thomsen, C. B., & Weller, M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.204 · Cited by 662
Agnelli, G., Piovella, F., Buoncristiani, P., Severi, P., Pini, M., D'Angelo, A., Beltrametti, C., Damiani, M., Andrioli, G. C., Pugliese, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390204 · Cited by 523
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802997-8.00023-2 · Cited by 472
Murray, S. A., Kendall, M., Boyd, K., Worth, A., & Benton, T. F. (2004) · Palliative Medicine · doi:10.1191/0269216304pm837oa · Cited by 470
Self-citationCognitive Deficits before Treatment among Patients with Brain Tumors
Tucha, O., Smely, C., Preier, M., & Lange, K. W. (2000) · Neurosurgery · doi:10.1097/00006123-200008000-00011 · Cited by 398
Incidence of gliomas by anatomic location
Larjavaara, S., Mäntylä, R., Salminen, T., Haapasalo, H., Raitanen, J., Jääskeläinen, J., & Auvinen, A. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-016 · Cited by 396
Tamez-Pérez, H. E. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.1073 · Cited by 387
Brandes, A. A., Tosoni, A., Franceschi, E., Sotti, G., Frezza, G., Amistà, P., Morandi, L., Spagnolli, F., & Ermani, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4969 · Cited by 381
Risk factors for childhood and adult primary brain tumors
Ostrom, Q. T., Fahmideh, M. A., Cote, D. J., Muskens, I. S., Schraw, J. M., Scheurer, M. E., & Bondy, M. L. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz123 · Cited by 314
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma
Pace, A., Dirven, L., Koekkoek, J. A. F., Golla, H., Fleming, J., Rudà, R., Marosi, C., Rhun, E. L., Grant, R., Oliver, K., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30345-5 · Cited by 297
Rasmussen, B. K., Hansen, S., Laursen, R. J., Kosteljanetz, M., Schultz, H., Nørgård, B. M., Guldberg, R., & Gradel, K. O. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2607-5 · Cited by 280
A comprehensive profile of recurrent glioblastoma
Campos, B., Olsen, L. R., Urup, T., & Poulsen, H. S. (2016) · Oncogene · doi:10.1038/onc.2016.85 · Cited by 248
Glioblastoma in England: 2007–2011
Brodbelt, A., Greenberg, D., Winters, T., Williams, M., Vernon, S., & Collins, V. P. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.12.014 · Cited by 227
van Kessel, E., Baumfalk, A. E., van Zandvoort, M. J. E., Robe, P. A., & Snijders, T. J. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2503-z · Cited by 191
Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy: Table 1.
Armstrong, T. S., Grant, R., Gilbert, M. R., Lee, J. W., & Norden, A. D. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov269 · Cited by 181
Murray, S. A., Kendall, M., Boyd, K. J., Grant, L., Highet, G., & Sheikh, A. (2010) · BMJ · doi:10.1136/bmj.c2581 · Cited by 177
Self-citationMedical management of brain tumors and the sequelae of treatment
Schiff, D., Lee, E. Q., Nayak, L., Norden, A. D., Reardon, D. A., & Wen, P. Y. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou304 · Cited by 161
Lyratzopoulos, G., Abel, G. A., McPhail, S., Neal, R. D., & Rubin, G. P. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.1 · Cited by 160
Cavers, D., Hacking, B., Erridge, S., Kendall, M., Morris, P. G., & Murray, S. A. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.111622 · Cited by 138
Self-citationHoward, L. M. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.057851 · Cited by 133
Antiepileptic drugs as prophylaxis for post-craniotomy seizures
Weston, J., Greenhalgh, J., & Marson, A. G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007286.pub3 · Cited by 121
Pérez‐Larraya, J. G., & Hildebrand, J. G. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4088-7.00077-8 · Cited by 107
Presenting symptoms of glioma in adults
Posti, J. P., Bori, M., Kauko, T., Sankinen, M., Nordberg, J., Rahi, M., Frantzén, J., Vuorinen, V., & Sipilä, J. O. T. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12285 · Cited by 105
Rooney, A. G., McNamara, S., Mackinnon, M., Fraser, M., Rampling, R., Carson, A. J., & Grant, R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8466 · Cited by 100
Purdy, R. A., & Kirby, S. (2004) · Neurologic Clinics · doi:10.1016/s0733-8619(03)00099-9 · Cited by 94
Roth, P., Pace, A., Rhun, É. L., Weller, M., Ay, C., Moyal, E. C., Coomans, M. B., Giusti, R., Jordan, K., Nishikawa, R., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.11.003 · Cited by 94
Hamilton, W. T., & Kernick, D. P. (2007) · PubMed · Cited by 92
Jakola, A. S., Gulati, S., Weber, C., Unsgård, G., & Solheim, O. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028592 · Cited by 89
Aware, H. B. B. T., Aware, H. B. B. T., Walker, D., Wilne, S., Grundy, R. G., Kennedy, C., Neil, Dickson, A., Lindsell, S., Trusler, J., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov187 · Cited by 80
Pharmacological treatment of depression in patients with a primary brain tumour
Rooney, A. G., & Grant, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006932.pub3 · Cited by 79
Sagberg, L. M., Solheim, O. S., & Jakola, A. S. (2015) · Journal of neurosurgery · doi:10.3171/2015.4.jns15194 · Cited by 65
Walter, F. M., Penfold, C., Joannides, A. J., Saji, S., Johnson, M., Watts, C., Brodbelt, A. R., Jenkinson, M. D., Price, S. J., Hamilton, W. T., et al. (2019) · British Journal of General Practice · doi:10.3399/bjgp19x701861 · Cited by 50
Cognitive Screening in Brain Tumors: Short but Sensitive Enough?
Robinson, G. A., Biggs, V., & Walker, D. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00060 · Cited by 46
Kirby, S., & Purdy, R. A. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2013.11.006 · Cited by 45
Ozawa, M., Brennan, P. M., Zienius, K., Kurian, K. M., Hollingworth, W., Weller, D., Grant, R., Hamilton, W. T., & Ben‐Shlomo, Y. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029686 · Cited by 34
Diagnosing adult primary brain tumours: can we do better?
Penfold, C., Joannides, A. J., Bell, J., & Walter, F. M. (2017) · British Journal of General Practice · doi:10.3399/bjgp17x691277 · Cited by 24
Tsien, C. I., Pugh, S. L., Dicker, A. P., Raizer, J. J., Matuszak, M. M., Lallana, E. C., Huang, J., Algan, Ö., Taylor, N., Portelance, L., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz175.075 · Cited by 15
Thrombotic Complications in Gliomas
Czap, A. L., Becker, A., & Wen, P. Y. (2019) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0039-1687892 · Cited by 14
Cited by
Unraveling the impact of miR-21 on apoptosis regulation in glioblastoma
Shaikh, M. A. J., Altamimi, A. S. A., Afzal, M., Gupta, G., Singla, N., Gilhotra, R., almalki, W. H., Kazmi, I., Alzarea, S. I., Prasher, P., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155121 · Cited by 37
MiR-128-3p – a gray eminence of the human central nervous system
Kiel, K., Król, S. K., Bronisz, A., & Godlewski, J. (2024) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2024.102141 · Cited by 15
Advances of MR imaging in glioma: What the neurosurgeon needs to know
Falk Delgado, A. (2025) · Acta Neurochirurgica · doi:10.1007/s00701-025-06593-6 · Cited by 14
Metadata
- Authors
- McKinnon, C., Nandhabalan, M., Murray, S. A., & Plaha, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2021-07-14
- Volume
- 374
- Pages
- n1560
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3178127564
- Cited by
- 391
- References
- 55
- FWCI
- 28.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.